Maravai LifeSciences (MRVI) reported Q2 EPS of $0.53, $0.08 better than the analyst estimate of $0.45. Revenue for the quarter came in at $242.7 million versus the consensus estimate of $234.47 million.
Maravai LifeSciences (MRVI) reported Q2 EPS of $0.53, $0.08 better than the analyst estimate of $0.45. Revenue for the quarter came in at $242.7 million versus the consensus estimate of $234.47 million.